Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638637 · ClinicalTrials.gov registry record
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 1,492
- Enrollment target
NCT01638637: Completed study, sponsored by Gen-Probe, Incorporated.
NCT01638637 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 1,492 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01638637 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 1,492 participants
- Enrollment target
Study Summary
The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs and male first-catch urine and urethral swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® System
Interventions
- DEVICE APTIMA Assays; PANTHER System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,492 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-07 |
What the finished NCT01638637 record still lists
NCT01638637 is an observational study that tracks outcomes without assigning an intervention. Its 1,492 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which APTIMA Assays; PANTHER System is the first listed.
NCT01638637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01638637 about?
NCT01638637 is a clinical study titled "Prospective Collection of Female and Male Specimens for PANTHER® System Testing". The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs and male first-catch urine and urethral swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® System
What is the current status of trial NCT01638637?
This trial is currently completed. The enrollment target is 1,492 participants. The study started on 2012-02. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01638637?
The interventions under investigation include: APTIMA Assays; PANTHER System (DEVICE).
Who is sponsoring clinical trial NCT01638637?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia